|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Retraction
for Tian et al.,
First published online November 28, 2005
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retraction |
Hua Tian, Toyoaki Tenzen and Andrew P. McMahon Development 131, 4021-4033.
A re-examination within our laboratory of two papers published by our group
in Development (Tian et al.,
2004
; Tian et al.,
2005
) has revealed a duplication of Dr Tian's data in these
papers. On review, we have found that the documentation underpinning a number
of conclusions in Tian et al.,
2004
is inadequate. As a consequence, we regret that we must
retract Tian et al., 2004
.
The principal conclusions in Tian et
al., 2005
are supported by appropriate documentation.
Nevertheless, to confirm the conclusions drawn from Dr Tian's primary data on
the tissue requirement for Dispatched in facial development, we will repeat
the experiments documented in Figure 2 of
Tian et al., 2005
, and will
report our findings to the journal once these experiments have been concluded.
We do not expect this re-analysis to change the conclusions drawn in this
paper.
We apologize to the editors and readership of Development.
Andrew McMahon, Hua Tian* and Toyo Tenzen
Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138, USA
*Present address: 2548 Post Street, San Francisco, CA 94115, USA
REFERENCES
Tian, H., Tenzen, T. and McMahon, A. P. (2004).
Dose dependency of Disp1 and genetic interaction between
Disp1 and other hedgehog signaling components in the mouse.
Development 131,4021
-4033.
Tian, H., Jeong, J., Harfe, B. D., Tabin, C. J. and McMahon, A.
P. (2005). Mouse Disp1 is required in sonic
hedgehog-expressing cells for paracrine activity of the cholesterol-modified
ligand. Development 132,133
-142.
This article has been cited by other articles:
![]() |
H. Tian, J. Jeong, B. D. Harfe, C. J. Tabin, and A. P. McMahon Mouse Disp1 is required in sonic hedgehog-expressing cells for paracrine activity of the cholesterol-modified ligand Development, October 15, 2008; 135(20): 3471 - 3472. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||